InvestorsObserver
×
News Home

Should You Add Applied DNA Sciences Inc (APDN) Stock to Your Portfolio Friday?

Friday, October 06, 2023 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Applied DNA Sciences Inc (APDN) Stock to Your Portfolio Friday?

Applied DNA Sciences Inc (APDN) is near the top in its sector according to InvestorsObserver. APDN gets an overall rating of 45. That means it scores higher than 45% of stocks. Applied DNA Sciences Inc gets a 80 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 45
APDN has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on APDN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Applied DNA Sciences Inc Stock Today?

Applied DNA Sciences Inc (APDN) stock is up 0.93% while the S&P 500 is down -0.16% as of 10:30 AM on Friday, Oct 6. APDN is up $0.01 from the previous closing price of $1.09 on volume of 5,116 shares. Over the past year the S&P 500 is higher by 13.54% while APDN is down -28.57%. APDN lost -$0.55 per share the over the last 12 months. Click Here to get the full Stock Report for Applied DNA Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App